Work

Use of next-generation sequencing (NGS) to identify actionable genomic alterations (GA) in diverse solid tumor types: The Foundation Medicine (FMI) experience with 2,200+ clinical samples.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.11020

Authors: Vincent A. Miller, Jeffrey S. Ross, Kai Wang, Siraj M. Ali, Geoff Otto, John Curran, Norma Alonzo Palma, Roman Yelensky, Sean Downing, Phil Stephens, Doron Lipson, Gary A. Palmer

Institution: Foundation Medicine (United States)

Language: English

Topic: Cancer Genomics and Diagnostics

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2315704360

Cites:

Cited by: 6

Related to: 10